NOVAQUEST CAPITAL MANAGEMENT
NovaQuest Capital Management, LLC (NovaQuest) manages product and company investments in the global healthcare industry. Its primary focus is structured finance investments in late-stage clinical and commercialized biopharmaceutical products. NovaQuest invests side-by-side with global companies in their most strategic product programs, ensuring alignment with the biopharmaceutical companies. These customized, product transactions are an alternative to standard biopharmaceutical industry deal-ma... king and help companies maximize the value of their product portfolios. In addition, NovaQuest invests in select private equity and other company securities, with a consistent focus on late-stage clinical and commercialized products. The NovaQuest team has worked together for over 12 years, investing over $1 billion into the global healthcare industry. The team began pursuing its strategy in 2000 as an investment group within Quintiles Transnational Holdings Inc. (Quintiles). Today, NovaQuest Capital Management is an independent firm managing global investment capital. It is backed by investors whose relationships with NovaQuest date back to the group’s inception. NovaQuest is meeting the evolving needs of global healthcare companies and its investors with a consistent strategy, developed over multiple years and transactions, that draws on a customized mix of investment and return elements and securities.
NOVAQUEST CAPITAL MANAGEMENT
Social Links:
Founded:
2010-01-01
Status:
Active
Contact:
919.459.8620
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Rex Health Ventures
Rex Health Ventures is the corporate venture arm of UNC Healthcare and invests in cutting edge healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-07-07 | Lexitas Pharma Services | Lexitas Pharma Services acquired by Novaquest Capital Management | N/A |
2021-11-30 | Covenant Animal Health Partners | Covenant Animal Health Partners acquired by Novaquest Capital Management | N/A |
2021-02-23 | Pro-ficiency | Pro-ficiency acquired by Novaquest Capital Management | N/A |
2021-01-19 | CoreRx | CoreRx acquired by Novaquest Capital Management | N/A |
2018-11-01 | Catalyst Clinical Research | Catalyst Clinical Research acquired by Novaquest Capital Management | N/A |
2018-03-26 | Azurity Pharmaceuticals | Azurity Pharmaceuticals acquired by Novaquest Capital Management | N/A |
2018-01-03 | Viamet Pharmaceuticals | Viamet Pharmaceuticals acquired by Novaquest Capital Management | N/A |
2014-08-20 | California Cryobank | California Cryobank acquired by Novaquest Capital Management | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-18 | Hansa Biopharma | Novaquest Capital Management investment in Grant - Hansa Biopharma | 70 M USD |
2022-05-25 | TARGAN | Novaquest Capital Management investment in Series C - TARGAN | 35 M USD |
2021-06-07 | Dermavant Sciences | Novaquest Capital Management investment in Private Equity Round - Dermavant Sciences | 160 M USD |
2021-05-20 | Argenta | Novaquest Capital Management investment in Private Equity Round - Argenta | 30 M USD |
2021-05-03 | Aceragen | Novaquest Capital Management investment in Private Equity Round - Aceragen | 35 M USD |
2021-04-13 | Cerevel Therapeutics | Novaquest Capital Management investment in Post-IPO Equity - Cerevel Therapeutics | 125 M USD |
2020-10-19 | Mileutis | Novaquest Capital Management investment in Venture Round - Mileutis | 20 M USD |
2020-05-27 | Arvelle Therapeutics | Novaquest Capital Management investment in Series A - Arvelle Therapeutics | 42.7 M USD |
2019-12-24 | InformedDNA | Novaquest Capital Management investment in Venture Round - InformedDNA | N/A |
2019-06-18 | Nevakar | Novaquest Capital Management investment in Private Equity Round - Nevakar | 50 M USD |